Author(s): Gouteux JP, Bansimba P, Noireau F, Frezil JL
Abstract Share this page
Abstract A survey carried out on 101 patients has shown that the treatment of human sleeping sickness, theoretically free, is relatively costly. The average total cost amount to 58,000 F C.F.A., ranging from free treatment up to much as 110,000 F C.F.A. This high cost in part explains the cases where treatment is refused, something which has frequently been observed in the Congo. It would therefore be desirable for patients, who are significant epidemiological reservoirs of T. b. gambiense, to receive economic aid.
This article was published in Med Trop (Mars)
and referenced in Journal of Clinical & Experimental Pathology